Curcumin Phytosome Sustained Release — Meriva® (120 Caps)
Curcumin Phytosome Sustained Release by Thorne features Meriva® — the most clinically studied curcumin on the market — in a time-released delivery system that provides consistent anti-inflammatory action throughout the day. With 29x greater bioavailability than ordinary curcumin and a sustained-release matrix, this is the gold standard for curcumin supplementation.*
Key Benefits

Meriva® curcumin phytosome — 29x greater absorption than standard curcumin*
Sustained-release formula provides extended anti-inflammatory support*
Supports healthy cytokine balance and NF-kB pathway modulation*
Promotes joint comfort, mobility, and connective tissue health*
Supports brain health, mood, and neuroprotection*

Who Is This For?
This formula is ideal for individuals with chronic inflammatory conditions (arthritis, autoimmune, inflammatory bowel), those seeking joint and mobility support, people looking for sustained anti-inflammatory coverage throughout the day, and anyone who wants the most clinically validated curcumin available. Curated by Michelle Tonkin ND for comprehensive inflammation support.
Suggested Use
Take 2 capsules daily with food, or as directed by your healthcare practitioner. The sustained-release feature reduces the need for multiple daily doses.
Frequently Asked Questions
Q: Why is this better than regular turmeric supplements?
A: Standard curcumin has very poor bioavailability — your body absorbs very little. The Meriva® phytosome complex dramatically increases absorption, and the sustained-release formula maintains therapeutic blood levels longer than standard formulas.
Q: How does curcumin compare to NSAIDs for inflammation?
A: Research suggests Meriva® curcumin rivals ibuprofen's anti-inflammatory effects for conditions like arthritis, with far fewer gastrointestinal side effects.*
Q: Is this safe for long-term use?
A: Curcumin has an excellent long-term safety profile and is one of the most well-researched botanical anti-inflammatories available.